Skip to main content
. 2014 Oct-Dec;7(4):572–576.

Table 1.

Overall survival for stage IV patients according to first metastatic site

Time BRA DYG PUL LYM+SC
3 months 40.7% 87.5% 77.8% 100%
6 months 18.5% 35.0% 64.8% 80%
9 months 9.9% 17.5% 64.8% 73.3%
1 year 0% 0% 64.8% 66.0%
2 years 0% 0% 21.6% 25.7%
BRA – brain metastasis; DYG – liver and gastrointestinal tract metastasis; PUL – lung metastasis; LYM+SC - extra-regional lymph nodes and subcutaneous metastasis